We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




BD to Acquire CareFusion for USD 12.2 Billion

By HospiMedica International staff writers
Posted on 07 Oct 2014
BD (Franklin Lakes, NJ, USA), formerly Becton Dickinson & Co, and CareFusion (San Diego, CA, USA) have announced a definitive agreement under which BD will acquire CareFusion, creating a global leader in medication management and patient safety solutions.

The combination of the two companies' complementary product portfolios will offer integrated medication management solutions and smart devices, from drug preparation in the pharmacy, to dispensing on the hospital floor, administration to the patient, and subsequent monitoring. More...
The combination is designed to address unmet needs in hospitals, hospital pharmacies, and alternate sites of care by increasing efficiencies, reducing medication administration errors, and improving patient and healthcare worker safety.

The acquisition is designed to accelerate BD's strategy to improve quality of care and reduce healthcare costs, as well as enhances emerging market growth opportunities. A detailed execution plan will be implemented to ensure a seamless integration, following which CareFusion will operate as part of BD's medical segment. A designated integration team, comprised of senior members of both organizations, will identify potential areas to consolidate cost synergies.

“BD's acquisition of CareFusion allows us to align our highly complementary technologies and products to address unmet needs in the growing 20 billion global medication management industry, which leverages BD's world-wide infrastructure,” said Vincent Forlenza, chairman, CEO, and president of BD. “It accelerates BD's transition from a product-focused company to a customer-centric provider of innovative healthcare solutions with leading scale across the medication management value chain and expanded solutions for patient safety.”

“As part of BD, we see new growth opportunities for our products in global markets, new value we can create for our customers and new opportunities for our employees as part of what will become one of the largest, global leaders in med-tech,” said Kieran Gallahue, chairman and CEO of CareFusion. “The transaction delivers attractive value for CareFusion shareholders, and represents a powerful endorsement of our strong positions in medication management, informatics across our device platforms and leading products to help improve the effectiveness of acute-care procedures.”

BD is a medical technology company that manufactures and sells a broad range of medical supplies, devices, laboratory equipment, and diagnostic products to healthcare institutions, life science researchers, clinical laboratories, industry, and the general public.

CareFusion is a global medical technology corporation that specializes in two areas—reducing medication errors and prevention of health care-associated infections.

Related Links:

BD
CareFusion



Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
New
Dual-Screen Medical Display
C822W
New
Sling
GoComfort
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: A mechanosensing-based approach offers a potential path to the treatment for cardiac fibrosis (Photo courtesy of Adobe Stock)

Mechanosensing-Based Approach Offers Promising Strategy to Treat Cardiovascular Fibrosis

Cardiac fibrosis, which involves the stiffening and scarring of heart tissue, is a fundamental feature of nearly every type of heart disease, from acute ischemic injuries to genetic cardiomyopathies.... Read more

Surgical Techniques

view channel
Image: Bioprinting synthetic vasculature could dramatically change how cardiovascular diseases are treated (Dell, A.C., Maresca, J., Davis, B.A. et al.; doi.org/10.1038/s41598-025-93276-y)

Bioprinted Aortas Offer New Hope for Vascular Repair

Current treatment options for severe cardiovascular diseases include using grafts made from a patient's own tissue (autologous) or synthetic materials. However, autologous grafts require invasive surgery... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.